Comment on Using video games as medical treatments seemed promising, but a stunning failure raises questions about the future of digital th

Using video games as medical treatments seemed promising, but a stunning failure raises questions about the future of digital th

A child plays EndeavorRx, Akili's prescription video game for ADHD.Akili Interactive The digital-therapeutics pioneer Pear was sold for parts in an auction on May 18 for $6 million. Companies like Pear and Akili have struggled to get payers and providers on board with their tech. Experts warn more that failures may be on the horizon for the $3.9 billion industry. A group of healthcare companies has spent the past decade building new technologies to treat patients with prescription software, creating an industry worth $3.9 billion and growing fast.But the industry's pioneers have stumbled, raising questions about the future of the nascent market — including which companies will make it to the other side.In 2017, Pear Therapeutics became the first company to receive clearance from the Food and Drug Administration for a prescription digital therapeutic, with its app to treat substance-use disorders.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News